Henry Staines

Following a BSc in Biochemistry at the University of Kent at Canterbury, Dr. Henry Staines studied for a DPhil in Cellular Physiology at the University Laboratory of Physiology, Oxford. During this time and his initial postdoctoral years, he examined the transport mechanisms used by the malaria parasite, Plasmodium falciparum, to obtain nutrients and export waste products while developing within human red blood cells. During a Wellcome Trust Research Career Development Fellowship (2005–09), he studied transport mechanisms in a wider range of unicellular parasites. Now, Dr. Henry Staines has developed interest point-of-care diagnostics for malaria, which also aims to diagnose drug resistance in the parasite. This has led to translation of scientific studies (some that he has been involved with himself) to patient care and has provided him with great experience in managing (with others) a complex EU project like Nanomal.

Lab Information

St George’s University of London

Research Area and Skills

Recognize this scientist’s Expertise for their contribution in your research

Malaria 0 Interest point-of-care diagnostics 0 diagnose drug resistance 0

More

  • Post
  • Publication
  • Plasmid
  • Following (0)
  • Follower (1)


This guy hasn’t posted anything yet.

Hot Posts for You

Neutralizing antibodies (NAbs) are critical human immune defense mechanisms against viral infections. NAbs can bind to sites on the virus and inhibit entry of that virus into the host. It is a key parameter to evaluate COVID-19 vaccine efficacy per Guidelines from Development and ...Learn More


This 3D animation shows you how DNA is copied in a cell. It shows how both strands of the DNA helix are unzipped and copied to produce two identical DNA molecules. TranscriptDNA is a molecule made up of two strands twisted around each other in a double helix shape. Each strand is ...Learn More


IntroductionA gleam of light finally shone down on the global crisis of the prolonged battle against COVID-19, giving people hopes of preventive care and treatment in the near future by monoclonal antibodies against SARS-CoV-2. As stated the news of NIH’s phase III clinical ...Learn More


"Those who do not know history are obliged to repeat it" This famous phrase that could be from any history teacher to his suspended students has been attributed to great figures in history such as Napoleon or the philosopher George Santayana. In a modern version of it we could say ...Learn More


In recent years there is an increasing number of cytotoxic chemotherapeutic compounds with the ability to rapidly kill dividing cancer cells in preference to non-dividing healthy cells. Nevertheless, the major drawback of chemotherapy is that, in addition to damaging the cancer ...Learn More


The coronavirus pandemic caught everyone unprepared. We had to deal with the fear of an unknown virus which can be lethal for some people. And the whole world just stopped in an attempt to prevent the virus spread.Suddenly we had to adapt to a new way of living, socially isolated ...Learn More


This is the first episode of MolecularCloud Pioneer Scientist interview series. In this interview, MolecularCloud talks with Prof. Shuo Huang from Nanjing University about the recent publications of Dr. Huang’s team and the future prospect of biological nanopore technology. The ...Learn More


The increasing number of confirmed COVID-19 cases is prompting an unprecedented global effort to find a treatment for the disease. Given the fact that a new drug development could be a decade work from initial discovery to the marketplace, scientists are racing to search a cure ...Learn More


The previous article on precision medicine was focused on Pharmacogenomics as a fundamental aspect of cancer therapeutics. In this sequel, emphasis would be on the role of immuno-oncology in personalization of cancer therapy, citing anti PD therapy as an example with hypothetical ...Learn More


  1. H. M. Staines, S. Ashmore, H. Felgate, J. Moore, T. Powell and J. C. Ellory (2006). Solute transport via the new permeability pathways inPlasmodium falciparum-infected human red blood cells is not consistent with a simple single channel model. Blood, 108, 3187-3194

  2. H. M. Staines, T. Powell, J. C. Ellory, S. Egée, F. Lapaix, G. Decherf, S. L. Y. Thomas, C. Duranton, F. Lang and S. M. Huber (2003). Modulation of whole-cell currents in Plasmodium falciparum-infected human red blood cells by holding potential and serum. J. Physiol., 552, 177-183

  3. H. M. Staines, J. C. Ellory and K. Kirk (2001). Perturbation of the pump-leak balance for Na+ and K+ in malaria-infected erythrocytes. Am. J. Physiol., 280, C1576-C1587


This guy has no following anyone.

Popular Cloud Scientists

Cloud Scientists

About Us · User Accounts and Benefits · Privacy Policy · Management Center · FAQs
© 2025 MolecularCloud